Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov
Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby

LOBBYING REGISTRATION

Lobbying Disclosure Act of 1995 (Section 4)

Check One: New Registrant New Client for Existing Registrant Amendment

1. Effective Date of Registration
3/1/2017
2. House Identification
 41166
Senate Identification
 400531586

REGISTRANT Organization/Lobbying Firm Self Employed Individual

3. Registrant Organization
Crossroads Strategies, LLC
Address
800 North Capitol Street, NW, Suite 800
Address2
​
City
Washington
State
DC
Zip
20002
Country
USA

4. Principal place of business (if different than line 3)

City
​
State
​
Zip
​
Country
​
5. Contact name and telephone number International Number
Contact
​Mr. John Green
Telephone
​2025590170
E-mail
​jgreen@crshq.com
6. General description of registrant’s business or activities
​lobbying firm

CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self

7. Client name
​Pharmaceutical Research and Manufacturers of America
Address
​950 F Street, NW, Suite 300
City
​Washington
State
​DC
Zip
​20004
Country
​USA
8. Principal place of business (if different than line 7)
City
​
State
​
Zip
​
Country
​
9. General description of client’s business or activities
​represents biopharmaceutical research companies

LOBBYISTS

10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.

Name Covered Official Position (if applicable)
First
Last
Suffix
​Jason ​Van Pelt ​ ​Legislative Director, Senior LA, LA, Staff Asst: Cong. Ed Whitfield
​Hunter ​Moorhead ​ ​Adv,Cochran;NatlEcoCoun;SenAppro;LACochran;HRAg;LAParker
​Mathew ​Lapinski ​ ​
​Stewart ​Hall ​ ​
​Shay ​Hancock ​ ​MLA Sen. Murray (D-WA), LA Rep Smith (D-WA)

LOBBYING ISSUES

11. General lobbying issue areas (Select all applicable codes).

​HCR
​MMM
​BUD
​
​
​
​
​
​

12. Specific lobbying issues (current and anticipated)

Reauthorization of Prescription Drug User Fee Act (PDUFA), Generic Drug User Fee Act (GDUFA), and Biologics Drug User Fee Act (BDUFA); 340B drug discount program; truthful non-misleading industry communications; compassionate use/right to try; importation of biopharmaceuticals; drug pricing; Part D Medicare program; non-interference; CMMI; IPAB repeal; Valued-Based Payments; Medicare Part B reimbursement. FY2017/FY2018, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; funding issues related to the pharmaceutical industry.


AFFILIATED ORGANIZATIONS

13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?

No --> Go to line 14. Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14.

Internet Address:
​http://www.phrma.org/about/members
Name Address Principal Place of Business
Street
City State/Province Zip Code Country
​
​
City
​
​
​
​
​
State
​
Country
​
​
​
City
​
​
​
​
​
State
​
Country
​
​
​
City
​
​
​
​
​
State
​
Country
​

FOREIGN ENTITIES

14. Is there any foreign entity

a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or

b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or

c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?

No --> Sign and date the registration. Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration.

Address Ownership
Name Street Principal place of business Amount of contribution
City State/Province Country
(city and state or country) for lobbying activities

​
City
​
​
​
​
​
State
​
Country
​
​
​
%
​
City
​
​
​
​
​
State
​
Country
​
​
​
%

Signature
Digitally Signed By: John Green
Date
3/31/2017 9:55:51 AM